XML 29 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:    
Net income $ 81,521 $ 96,988
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 171,708 140,315
Accretion expense 16,521 15,434
Deferred income tax provision 46,474 57,664
Settlement of asset retirement obligations (21,918) (33,568)
Non-cash stock compensation expense 4,271 3,138
Excess tax benefits (795) (1,060)
Non-cash derivative income (2,758) (118)
Loss on early extinguishment of debt   607
Non-cash interest expense 5,278 959
Change in current income taxes (3,921) (6,245)
Increase in accounts receivable (37,517) (37,428)
Increase in other current assets (124) (476)
Decrease in inventory 36 1,163
Increase in accounts payable 8,413 5,854
Increase (decrease) in other current liabilities (17,304) 4,440
Other (465) (1,135)
Net cash provided by operating activities 249,420 246,532
Cash flows from investing activities:    
Investment in oil and gas properties (275,813) (272,451)
Proceeds from sale of oil and gas properties, net of expenses 403 6,692
Sale of fixed assets 149  
Investment in fixed and other assets (1,900) (894)
Net cash used in investing activities (277,161) (266,653)
Cash flows from financing activities:    
Proceeds from bank borrowings 25,000  
Repayments of bank borrowings (70,000)  
Proceeds from issuance of senior convertible notes 300,000  
Financing costs of senior convertible notes (8,855)  
Proceeds from Sold Warrants 40,170  
Payments for Purchased Call Options (70,830)  
Deferred financing costs   (4,017)
Excess tax benefits 795 1,060
Net payments for share based compensation (3,141) (1,857)
Net cash provided by (used in) financing activities 213,139 (4,814)
Net change in cash and cash equivalents 185,398 (24,935)
Cash and cash equivalents, beginning of period 38,451 106,956
Cash and cash equivalents, end of period $ 223,849 $ 82,021